Six-year review of Acanthamoeba keratitis in New South Wales, Australia: 1997-2002

Clinical and Experimental Ophthalmology

Volumn 33, Issue 1, 2005, Pages 41-46

  Butler, Tom K H ^a   Males, John J ^a   Robinson, Lyon P ^a   Wechsler, Alfred W ^a   Sutton, Gerard L ^a   Cheng, Joanna ^b   Taylor, Peter ^b   McClellan, Kathleen ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Acanthamoeba; Contact lens; Keratitis

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; CHLORHEXIDINE; METHOTREXATE; MYDRIATIC AGENT; NEOSPORIN; POLY(HEXAMETHYLENEBIGUANIDE); PROPAMIDINE ISETHIONATE; STEROID;

ACANTHAMOEBA KERATITIS; ADULT; ARTICLE; AUSTRALIA; CLINICAL ARTICLE; CONTACT LENS; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; FEMALE; FOLLOW UP; HERPES SIMPLEX KERATITIS; HUMAN; INCIDENCE; MALE; OUTCOMES RESEARCH; PERSONAL HYGIENE; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK FACTOR; VISUAL ACUITY;

ACANTHAMOEBA KERATITIS; ADOLESCENT; ADULT; AGED; ANTIPROTOZOAL AGENTS; CONTACT LENSES; CORNEA; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEW SOUTH WALES; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 14744293557     PISSN: 14426404     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2004.00911.x     Document Type: Article

References (17)

1. Nagington J, Watson PG, Playfair TJ et al. Amoebic infection of the eye. Lancet 1974; 2: 1537-40.
2. Wright P, Warhurst D, Jones BR. Acanthamoeba keratitis successfully treated medically. Br J Ophthalmol 1985; 69: 778-82.
3. Larkin DFP, Kilvington S, Dart JK. Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide. Ophthalmology 1992; 99: 185-91.
4. Seal DV, Hay J, Kirkness C et al. Successful medical therapy of acanthamoeba keratitis with topical chlorhexidine and propamidine. Eye 1996; 10: 413-21.
5. Radford CF, Minassian DC, Dart JK. Acanthamoeba keratitis in England and Wales: incidence, outcome, and risk factors. Br J Ophthalmol 2002; 86: 536-42.
6. Bacon AS, Frazer DG, Dart JK et al. A review of 72 consecutive cases of Acanthamoeba keratitis, 1984-1992. Eye 1993; 7: 719-25.
7. Duguid IG, Dart JK, Morlet N et al. Outcome of Acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine. Ophthalmology 1997; 104: 1587-92.
8. Lee GA, Gray TB, Dart JK et al. Acanthamoeba sclerokeratitis: treatment with systemic immunosuppression. Ophthalmology 2002; 109: 1178-82.
9. Pérez-Santonja JJ, Kilvington S, Hughes R et al. Persistently culture positive Acanthamoeba keratitis, in vitro resistance and in vitro sensitivity. Ophthalmology 2003; 110: 1593-600.
10. Dougherty PJ, Binder PS, Mondino BJ, Glasgow BJ. Acanthamoeba sclerokeratitis. Am J Ophthalmol 1994; 117: 475-9.
11. Park DH, Palay DA, Daya SM et al. The role of topical corticosteroids in the management of Acanthamoeba keratitis. Cornea 1997; 16: 277-83.
12. Horsburgh B, Hirst LW, Carey T et al. Steroid sensitive Acanthamoeba keratitis. Aust NZ J Ophthalmol 1991; 19: 349-50.
13. McClellan K, Howard K, Niederkorn JY et al. Effect of steroids on Acanthamoeba cysts and trophozoites. Invest Ophthalmol Vis Sci 2001; 42: 2885-93.
14. Johns KJ, O'Day DM, Head WS. Herpes simplex masquerade syndrome: acanthamoeba keratitis. Curr Eye Res 1987; 6: 207-12.
15. Lehmann OJ, Green SM, Morlet N et al. Polymerase chain reaction analysis of corneal epithelial and tear samples in the diagnosis of Acanthamoeba keratitis. Invest Ophthalmol Vis Sci 1998; 39 1261-5.
16. Pasricha G, Sharma S, Garg P et al. Use of 18s rRNA gene-based PCR assay for diagnosis of Acanthamoeba keratitis in non-contact lens wearers in India. J Clin Microbiol 2003; 41: 3206-11.
17. Mathers WD, Nelson SE, Lane JL et al. Confirmation of confocal microscopy diagnosis of Acanthamoeba keratitis using polymerase chain reaction analysis. Arch Ophthalmol 2000; 118: 178-83.